| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1697722 | A | Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset | 530 | ALA1697692 | assay format | Scientific Literature | ||
| 2. | ALA1697730 | A | Human drug-induced liver injury (DILI) modelling dataset from Ekins et al | Homo sapiens | 529 | ALA1697723 | tissue-based format | Scientific Literature | |
| 3. | ALA1697778 | A | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | Homo sapiens | 944 | ALA1697731 | tissue-based format | Scientific Literature | |
| 4. | ALA1697779 | A | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | Rodentia | 944 | ALA1697731 | tissue-based format | Scientific Literature | |
| 5. | ALA1697780 | A | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | 944 | ALA1697731 | tissue-based format | Scientific Literature | ||
| 6. | ALA1697797 | A | FDA HLAED, liver enzyme composite activity | Homo sapiens | 486 | ALA1697781 | tissue-based format | Scientific Literature | |
| 7. | ALA1697798 | A | FDA HLAED, alkaline phosphatase increase | Homo sapiens | 486 | ALA1697781 | assay format | Scientific Literature | |
| 8. | ALA1697799 | A | FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase | Homo sapiens | 486 | ALA1697781 | assay format | Scientific Literature | |
| 9. | ALA1697800 | A | FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase | Homo sapiens | 486 | ALA1697781 | assay format | Scientific Literature | |
| 10. | ALA1697801 | A | FDA HLAED, lactate dehydrogenase (LDH) increase | Homo sapiens | 486 | ALA1697781 | assay format | Scientific Literature | |
| 11. | ALA1697802 | A | FDA HLAED, gamma-glutamyl transferase (GGT) increase | Homo sapiens | 486 | ALA1697781 | assay format | Scientific Literature | |
| 12. | ALA1909291 | T | FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of most concern for DILI | 136 | ALA1909281 | tissue-based format | Scientific Literature | ||
| 13. | ALA1909292 | T | FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of less concern for DILI | 85 | ALA1909281 | tissue-based format | Scientific Literature | ||
| 14. | ALA1909293 | T | FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of no concern for DILI | 65 | ALA1909281 | tissue-based format | Scientific Literature | ||
| 15. | ALA1909307 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia | 888 | ALA1909294 | tissue-based format | Scientific Literature | ||
| 16. | ALA1909308 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis | 888 | ALA1909294 | tissue-based format | Scientific Literature | ||
| 17. | ALA1909309 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis | 888 | ALA1909294 | tissue-based format | Scientific Literature | ||
| 18. | ALA1909310 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis | 888 | ALA1909294 | tissue-based format | Scientific Literature | ||
| 19. | ALA1909311 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests | 888 | ALA1909294 | tissue-based format | Scientific Literature | ||
| 20. | ALA1909312 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure | 888 | ALA1909294 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!